Company Filing History:
Years Active: 2021-2025
Title: Innovations by Amruta Pise in COVID-19 Treatment
Introduction
Amruta Pise is an accomplished inventor based in San Carlos, California. She has made significant contributions to the field of medical science, particularly in the treatment of COVID-19. With a total of five patents to her name, her work focuses on innovative methods for diagnosing and treating COVID-related conditions.
Latest Patents
One of her latest patents involves methods of assigning a COVID pathological type based on a cytokine/chemokine panel. This method provides a way to determine the COVID pathological type for a subject suffering from COVID-19 by analyzing a quantitative, multiplex cytokine/chemokine panel in a test sample. Additionally, she has developed methods for treating long hauler subjects suffering from chronic COVID-19 by administering a CCR5/CCL5 interaction inhibitor. Another significant patent addresses the treatment of hypercytokinemia by using a CCR5 antagonist, which is crucial for assessing the severity of diseases like COVID-19.
Career Highlights
Amruta Pise is currently employed at Incelldx, Inc., where she continues to innovate in the field of medical diagnostics and treatment. Her work has been instrumental in developing therapies that improve patient outcomes in the context of COVID-19.
Collaborations
She collaborates with notable colleagues, including Edgar B Francisco and Bruce K Patterson, to advance her research and patent applications.
Conclusion
Amruta Pise's contributions to the medical field, particularly in the context of COVID-19, highlight her innovative spirit and dedication to improving patient care. Her patents reflect a commitment to addressing critical health challenges through scientific research and collaboration.